Incidence and severity of postoperative delirium associated with Dexmedetomidine sedation during femur osteosynthesis in the elderly population
Condition studied
Postoperative delirium
Investigational medicinal product(s)
Every trial of Propofol and Dexmedetomidine across our registers →
Eligibility
Primary endpoint
Prevalence, severity, and course of delirium during the postoperative period.
Endpoint detail
Clinical and epidemiological data, including factors associated with the onset of postoperative delirium., Sedative medications and administered doses, degree and quality of sedation as measured by the RASS scale (Appendix 1), events during sedation (episodes of agitation, need for restraint, etc.), and depth of sedation (BIS)., Clinical parameters (BP, SpO₂, HR, EtCO₂), basic laboratory tests (hemoglobin, electrolytes, blood glucose, and inflammatory markers such as CRP), and intra- and postoperative events (bleeding, blood product transfusion, hypertension/hypotension, desaturation, apnea, etc.)., Pain assessment (PA) and analgesia administered during the perioperative and postoperative periods.
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View 2025-523070-16-00 on CTIS ↗ ← All trials in the EU